{"result": {"id": "7db30776-e228-41b1-be15-b0f2833e486f", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "氯吡格雷（Clopidogrel）是一种抗血小板药物，主要用于预防和治疗血栓相关疾病，如心肌梗死和中风。作为P2Y12受体抑制剂，它通过阻断血小板活化来减少血栓形成。  \n\n氯吡格雷的药效可能受到药物相互作用的影响。当与奥美拉唑（omeprazole）或埃索美拉唑（esomeprazole）合用时，其抗血小板效果可能降低，因为这些质子泵抑制剂竞争性抑制CYP2C19酶，而该酶在氯吡格雷的代谢活化过程中起关键作用。此外，氯吡格雷本身也是CYP2C8酶的抑制剂，可能影响其他通过该酶代谢的药物。  \n\n值得注意的是，氯吡格雷与瑞格列奈（repaglinide）合用时可能增加低血糖风险，原因可能是氯吡格雷抑制CYP2C8酶，从而减缓瑞格列奈的代谢，导致其血药浓度升高。因此，联合用药时需密切监测血糖水平。  \n\n综上所述，氯吡格雷是一种有效的抗血小板药物，但其疗效和安全性可能受药物相互作用影响，尤其是与CYP2C19或CYP2C8酶相关的药物。临床使用时需注意潜在的相互作用风险，必要时调整治疗方案。", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752167528, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 259, "prompt_tokens": 205, "total_tokens": 464, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 128}, "prompt_cache_hit_tokens": 128, "prompt_cache_miss_tokens": 77}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or more entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\nLimit the final description length to 500 words.\n\n#######\n-Data-\nEntities: \"氯吡格雷\"\nDescription List: [\"Clopidogrel, an antiplatelet drug whose efficacy is reduced when used with omeprazole or esomeprazole due to CYP2C19 competition>\", \"氯吡格雷 is an inhibitor of CYP2C8\", \"氯吡格雷是一种抗血小板药物，与瑞格列奈合用可能导致低血糖\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_3f1821423839a96a7a3c8910a4d80160633be2c2cf2046d1ac6ca1cd91f40a21_v2"}